Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD ...

In the heart of Melbourne's business district, office blocks rise into the gloomy sky. The buildings are full of bankers and investment advisers from Australia's best-known institutions trusted to ...

Gift 5 articles to anyone you choose each month when you subscribe. While Donald Trump floods the news cycle with his endless stream of policy moves – crackdowns on skilled immigrants, prosecution of ...

I Am Legend 2 is officially in the works, with some of the big names behind the original back for the sequel. There's been talk of a follow-up to one of the best zombie movies for a few years now, but ...